Paul Edward Kelly, Chief Operating Officer at RELMADA THERAPEUTICS, INC. (RLMD), bought 180,000 shares at $2.20 ($396K) on 2025-11-05, disclosed to the SEC on 2025-11-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.20 | 90,000 | $198K | 50.0% |
| 2 | $2.20 | 90,000 | $198K | 50.0% |
| Total | $2.20 avg | 180,000 | $396K | 100% |
| Filing → |
| RLMD | SELL | 2022-04-05 | $300K | — | Filing → |
| RLMD | SELL | 2021-03-11 | $357K | — | Filing → |
| RLMD | SELL | 2021-02-26 | $338K | — | Filing → |